Vertex Pharma (NASDAQ: VRTX) notice: 4,062 shares proposed for resale on 06/15/2026
Rhea-AI Filing Summary
Filer submitted a Form 144 notice reporting a proposed sale of 4,062 shares of Common Stock on 06/15/2026. The filing lists $1,827,900.00 alongside 253,805,417 (appearing on the same cover line). The filing also records recent sales by Carmen Bozic, including 2,329 shares on 03/27/2026 and 6,988 shares on 05/12/2026.
Positive
- None.
Negative
- None.
Insights
Form 144 notifies the market of an intended resale of restricted/controlled securities.
The filing documents a proposed sale of 4,062 shares on 06/15/2026 and lists an associated dollar figure $1,827,900.00. It also itemizes recent dispositions by a holder, including sales on 03/27/2026 and 05/12/2026.
Form 144 is a notification: actual sale timing and methods are not specified in the excerpt. Subsequent trade reports or Form 4/Form 5 filings would show completed transactions and post-sale holdings.